Lataa...
Modulation of LMNA splicing as a strategy to treat prelamin A diseases
The alternatively spliced products of LMNA, lamin C and prelamin A (the precursor to lamin A), are produced in similar amounts in most tissues and have largely redundant functions. This redundancy suggests that diseases, such as Hutchinson-Gilford progeria syndrome (HGPS), that are caused by prelami...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4811112/ https://ncbi.nlm.nih.gov/pubmed/26999604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI85908 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|